Login / Signup

Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial.

Preston TseJiajun YanYang LiuErin JamulaNancy M HeddleRenée BazinNancy RobitailleRichard CookAlexis TurgeonDean FergussonMarshall GlesbyKent Cadogan LoftsgardMelissa M CushingMichaël ChasséNick DanemanAndrés FinziBruce SachaisPhilippe BéginJeannie CallumDonald M ArnoldFeng Xie
Published in: Transfusion (2024)
Convalescent plasma was less effective and more costly than standard care in treating hospitalized COVID-19.
Keyphrases
  • sars cov
  • healthcare
  • palliative care
  • quality improvement
  • coronavirus disease
  • pain management
  • study protocol
  • affordable care act
  • phase iii
  • phase ii
  • chronic pain